États-Unis - anglais - NLM (National Library of Medicine)

paddock laboratories, llc - sodium polystyrene sulfonate (unii: 1699g8679z) (polystyrene sulfonic acid - unii:70ko0r01ry) - sodium polystyrene sulfonate 4.1 meq in 1 g

États-Unis - anglais - NLM (National Library of Medicine)

trigen laboratories, llc - sodium polystyrene sulfonate (unii: 1699g8679z) (polystyrene sulfonic acid - unii:70ko0r01ry) - sodium cation 4.1 meq in 1 g

États-Unis - anglais - NLM (National Library of Medicine)

major pharmaceuticals - sodium polystyrene sulfonate (unii: 1699g8679z) (polystyrene sulfonic acid - unii:70ko0r01ry) - sodium polystyrene sulfonate 1 g in 1 g

États-Unis - anglais - NLM (National Library of Medicine)

bryant ranch prepack - sodium polystyrene sulfonate (unii: 1699g8679z) (polystyrene sulfonic acid - unii:70ko0r01ry) - sodium polystyrene sulfonate for suspension is indicated for the treatment of hyperkalemia. limitation of use : sodium polystyrene sulfonate for suspension should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action [see clinical pharmacology (12.2) ] sodium polystyrene sulfonate is contraindicated in patients with the following conditions: - hypersensitivity to polystyrene sulfonate resins - obstructive bowel disease - neonates with reduced gut motility risk summary sodium polystyrene sulfonate is not absorbed systemically following oral or rectal administration and maternal use is not expected to result in fetal risk. risk summary sodium polystyrene sulfonate is not absorbed systemically by the mother, so breastfeeding is not expected to result in risk to the infant. studies of safety and efficacy have not been conducted in pediatric patients. in pediatric patients, as in adults, sodium polystyrene sulfonate is expected to bind potassium at the pract

Japon - anglais - すりの適正使用協議会 RAD-AR Council, Japan

sanwa kagaku kenkyusho co.,ltd. - calcium polystyrene sulfonate - slightly yellowish white to pale yellow granules

Japon - anglais - すりの適正使用協議会 RAD-AR Council, Japan

fuso pharmaceutical industries, ltd. - calcium polystyrene sulfonate - faintly yellowish white to pale yellow powder

Japon - anglais - すりの適正使用協議会 RAD-AR Council, Japan

ono pharmaceutical co., ltd. - calcium polystyrene sulfonate - faintly yellowish white to pale yellow powder (powdered medicine)

Japon - anglais - すりの適正使用協議会 RAD-AR Council, Japan

fuso pharmaceutical industries, ltd. - sodium polystyrene sulfonate - yellowish brown powder

Canada - anglais - Health Canada

sanofi-aventis canada inc - calcium polystyrene sulfonate - powder for solution - 999mg - calcium polystyrene sulfonate 999mg - potassium-removing agents

Canada - anglais - Health Canada

pendopharm division of pharmascience inc - sodium polystyrene sulfonate - powder for suspension - 1g - sodium polystyrene sulfonate 1g - potassium-removing agents